JP2024510502A5 - - Google Patents
Info
- Publication number
- JP2024510502A5 JP2024510502A5 JP2023557351A JP2023557351A JP2024510502A5 JP 2024510502 A5 JP2024510502 A5 JP 2024510502A5 JP 2023557351 A JP2023557351 A JP 2023557351A JP 2023557351 A JP2023557351 A JP 2023557351A JP 2024510502 A5 JP2024510502 A5 JP 2024510502A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163162494P | 2021-03-17 | 2021-03-17 | |
| US63/162,494 | 2021-03-17 | ||
| PCT/US2022/020474 WO2022197755A1 (en) | 2021-03-17 | 2022-03-16 | Imidazopyridinyl inhibitors of plasma kallikrein |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024510502A JP2024510502A (ja) | 2024-03-07 |
| JP2024510502A5 true JP2024510502A5 (https=) | 2025-03-21 |
| JPWO2022197755A5 JPWO2022197755A5 (https=) | 2025-03-21 |
Family
ID=81325446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023557351A Pending JP2024510502A (ja) | 2021-03-17 | 2022-03-16 | 血漿カリクレインのイミダゾピリジニル阻害剤 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4308227A1 (https=) |
| JP (1) | JP2024510502A (https=) |
| CN (1) | CN117396473A (https=) |
| WO (1) | WO2022197755A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20200143376A (ko) | 2018-03-13 | 2020-12-23 | 샤이어 휴먼 지네틱 테라피즈 인크. | 혈장 칼리크레인 억제제로서의 치환된 이미다조피리딘 및 이의 용도 |
| CN114667289B (zh) | 2019-09-18 | 2025-08-26 | 武田药品工业有限公司 | 杂芳基血浆激肽释放酶抑制剂 |
| EP4031547B1 (en) | 2019-09-18 | 2024-07-17 | Takeda Pharmaceutical Company Limited | Plasma kallikrein inhibitors and uses thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4911920A (en) | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| ATE141502T1 (de) | 1991-01-15 | 1996-09-15 | Alcon Lab Inc | Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen |
| US5212162A (en) | 1991-03-27 | 1993-05-18 | Alcon Laboratories, Inc. | Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
| US6309853B1 (en) | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| US6887870B1 (en) * | 1999-10-12 | 2005-05-03 | Bristol-Myers Squibb Company | Heterocyclic sodium/proton exchange inhibitors and method |
| US20050192314A1 (en) * | 2003-11-13 | 2005-09-01 | Ambit Biosciences Corporation | Urea derivatives as C-kit modulators |
| MX2011012037A (es) * | 2009-05-13 | 2012-02-28 | Amgen Inc | Compuestos de heteroarilo como inhibidores de pikk. |
| EP2627178B1 (en) * | 2010-10-11 | 2018-05-02 | Merck Sharp & Dohme Corp. | Quinazolinone-type compounds as crth2 antagonists |
| EP3087067B1 (en) * | 2013-12-26 | 2018-10-24 | Takeda Pharmaceutical Company Limited | 4-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (magl) inhibitors |
| JP6665154B2 (ja) * | 2014-07-17 | 2020-03-13 | ノース・アンド・サウス・ブラザー・ファーマシー・インベストメント・カンパニー・リミテッド | 置換尿素誘導体及びその薬学的使用 |
| KR20200143376A (ko) * | 2018-03-13 | 2020-12-23 | 샤이어 휴먼 지네틱 테라피즈 인크. | 혈장 칼리크레인 억제제로서의 치환된 이미다조피리딘 및 이의 용도 |
| BR112023018619A2 (pt) * | 2021-03-17 | 2023-11-28 | Takeda Pharmaceuticals Co | Inibidores de heteroaril de calicreína plasmática |
| US20240382482A1 (en) * | 2021-03-17 | 2024-11-21 | Takeda Pharmaceutical Company Limited | Plasma kallikrein inhibitors |
-
2022
- 2022-03-16 CN CN202280033913.6A patent/CN117396473A/zh active Pending
- 2022-03-16 WO PCT/US2022/020474 patent/WO2022197755A1/en not_active Ceased
- 2022-03-16 EP EP22714692.5A patent/EP4308227A1/en active Pending
- 2022-03-16 JP JP2023557351A patent/JP2024510502A/ja active Pending